Central pontine myelinolysis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(6 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Central pontine myelinolysis}} | {{Central pontine myelinolysis}} | ||
{{CMG}} | |||
{{CMG}}; {{AE}} {{MMJ}} | |||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of central pontine myelinolysis is [[hyponatremia]]. Other risk factors include: Liver dysfunction and [[liver diseases]], [[hypocholesterolemia]], [[alcoholism]], [[malnutrition]], systemic medical disease and [[hemodialysis]]. | |||
==Risk Factors== | ==Risk Factors== | ||
===Common Risk Factors=== | |||
*The most potent risk factor in the development of central pontine myelinolysis is [[hyponatremia]]. | |||
*Other risk factors include:<ref name="pmid19797900">{{cite journal| author=Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS et al.| title=Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. | journal=Eur Neurol | year= 2009 | volume= 62 | issue= 6 | pages= 362-8 | pmid=19797900 | doi=10.1159/000242426 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19797900 }} </ref><ref name="pmid24716023">{{cite journal| author=Jacob S, Gupta H, Nikolic D, Gundogdu B, Ong S| title=Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case report. | journal=Case Rep Neurol Med | year= 2014 | volume= 2014 | issue= | pages= 745347 | pmid=24716023 | doi=10.1155/2014/745347 | pmc=3970353 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24716023 }} </ref><ref name="pmid15316041">{{cite journal| author=Martin RJ| title=Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 3 | issue= | pages= iii22-8 | pmid=15316041 | doi=10.1136/jnnp.2004.045906 | pmc=1765665 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15316041 }} </ref><ref name="pmid12535304">{{cite journal| author=Oo TN, Smith CL, Swan SK| title=Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review. | journal=Semin Dial | year= 2003 | volume= 16 | issue= 1 | pages= 68-71 | pmid=12535304 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12535304 }} </ref> | |||
**[[Liver dysfunction]] and [[liver diseases]] | |||
**[[Hypocholesterolemia]] | |||
**[[Alcoholism]] | |||
**[[Malnutrition]] | |||
**Systemic medical disease | |||
**[[Hemodialysis]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category: (name of the system)]] | |||
{{ | |||
{{ |
Latest revision as of 03:56, 15 August 2019
Central pontine myelinolysis Microchapters |
Differentiating Central pontine myelinolysis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Central pontine myelinolysis risk factors On the Web |
American Roentgen Ray Society Images of Central pontine myelinolysis risk factors |
Risk calculators and risk factors for Central pontine myelinolysis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
The most potent risk factor in the development of central pontine myelinolysis is hyponatremia. Other risk factors include: Liver dysfunction and liver diseases, hypocholesterolemia, alcoholism, malnutrition, systemic medical disease and hemodialysis.
Risk Factors
Common Risk Factors
- The most potent risk factor in the development of central pontine myelinolysis is hyponatremia.
- Other risk factors include:[1][2][3][4]
- Liver dysfunction and liver diseases
- Hypocholesterolemia
- Alcoholism
- Malnutrition
- Systemic medical disease
- Hemodialysis
References
- ↑ Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS; et al. (2009). "Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation". Eur Neurol. 62 (6): 362–8. doi:10.1159/000242426. PMID 19797900.
- ↑ Jacob S, Gupta H, Nikolic D, Gundogdu B, Ong S (2014). "Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case report". Case Rep Neurol Med. 2014: 745347. doi:10.1155/2014/745347. PMC 3970353. PMID 24716023.
- ↑ Martin RJ (2004). "Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii22–8. doi:10.1136/jnnp.2004.045906. PMC 1765665. PMID 15316041.
- ↑ Oo TN, Smith CL, Swan SK (2003). "Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review". Semin Dial. 16 (1): 68–71. PMID 12535304.